Please use this identifier to cite or link to this item: https://repository.monashhealth.org/monashhealthjspui/handle/1/28892
Title: Animal Models of ANCA Associated Vasculitis.
Authors: Shochet L.;Kitching A.R. ;Holdsworth S. 
Monash Health Department(s): Paediatric - Nephrology
Nephrology
Immunology and Allergy
Institution: (Shochet, Holdsworth, Kitching) Centre for Inflammatory Diseases, Monash University, Department of Medicine, Monash Medical Centre, Clayton, VIC, Australia (Shochet, Holdsworth, Kitching) Department of Nephrology, Monash Health, Clayton, VIC, Australia (Holdsworth) Department of Immunology, Monash Health, Clayton, VIC, Australia (Kitching) Department of Pediatric Nephrology, Monash Health, Clayton, VIC, Australia
Issue Date: 6-May-2020
Copyright year: 2020
Publisher: Frontiers Media S.A. (E-mail: info@frontiersin.org)
Place of publication: Switzerland
Publication information: Frontiers in Immunology. 11 (no pagination), 2020. Article Number: 525. Date of Publication: 09 Apr 2020.
Journal: Frontiers in Immunology
Abstract: Anti-neutrophil cytoplasmic antibody (ANCA) associated vasculitis (AAV) is a rare and severe autoimmune multisystemic disease. Its pathogenesis involves multiple arms of the immune system, as well as complex interactions between immune cells and target organs. Experimental animal models of disease can provide the crucial link from human disease to translational research into new therapies. This is particularly true in AAV, due to low disease incidence and substantial disease heterogeneity. Animal models allow for controlled environments in which disease mechanisms can be defined, without the clinical confounders of environmental and lifestyle factors. To date, multiple animal models have been developed, each of which shed light on different disease pathways. Results from animal studies of AAV have played a crucial role in enhancing our understanding of disease mechanisms, and have provided direction toward newer targeted therapies. This review will summarize our understanding of AAV pathogenesis as has been gleaned from currently available animal models, as well as address their strengths and limitations. We will also discuss the potential for current and new animal models to further our understanding of this important condition.© Copyright © 2020 Shochet, Holdsworth and Kitching.
DOI: http://monash.idm.oclc.org/login?url=http://dx.doi.org/10.3389/fimmu.2020.00525
PubMed URL: 32373109 [http://www.ncbi.nlm.nih.gov/pubmed/?term=32373109]
ISSN: 1664-3224 (electronic)
URI: https://repository.monashhealth.org/monashhealthjspui/handle/1/28892
Type: Review
Subjects: pathogenicity
protein expression
pulmonary vasculitis
regulatory T lymphocyte
spleen cell
Th17 cell
CD18 antigen
colony stimulating factor
complement component C5a receptor
CXCL1 chemokine
CXCL2 chemokine
endothelial leukocyte adhesion molecule 1
immunoglobulin G
interleukin 17
interleukin 8
lipopolysaccharide
lymphocyte function associated antigen 1
lysosome associated membrane protein 2
mannan binding lectin associated serine proteinase
neutrophil cytoplasmic antibody
phosphatidylinositol 3 kinase gamma
toll like receptor 4
tumor necrosis factor
MBL associated serine protease 2
T lymphocyte
ANCA associated vasculitis
antigen antibody complex
autoimmunity
bone marrow cell
CD4+ T lymphocyte
CD8+ T lymphocyte
endothelium injury
extracellular trap
glomerulonephritis
immune response
leukocyte activation
Type of Clinical Study or Trial: Review article (e.g. literature review, narrative review)
Appears in Collections:Articles

Show full item record

Page view(s)

36
checked on Sep 12, 2024

Google ScholarTM

Check


Items in Monash Health Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.